Regulatory News has published 1 story about TriSalus Life Sciences on 24 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 24 September 2026.
This page is generated from Regulatory News’ editorial coverage of TriSalus Life Sciences. It is not an advertisement.
On the record
- Company
- TriSalus Life Sciences, Inc. (Nasdaq: TLSI)
- Headquarters
- Westminster, Colorado
- Founded
- 2009, as Surefire Medical, Inc.; renamed TriSalus Life Sciences in 2018
- Regulator
- U.S. Food and Drug Administration (CDRH)
- Latest milestone
- FDA 510(k) clearance, TriNav Advance catheter
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
